Kirk Dornbush: Keeping the Ship Afloat – Corporate Survival During the 2008 Financial Crisis
Friday, 04 February 2022
Kirk started Iconic Therapeutics after licensing a novel treatment for wet age-related macular degeneration and cancer from Yale University. After raising $15M in Series A funding, they had completed the pre-clinical phase of the drug’s development and were ready for the all-important Phase 1 human safety studies. All that remained was to complete the final
- Published in View Point
Elizabeth Young: Medical Device Product Launch In 9-Months = $2 Million Sales
Wednesday, 23 September 2020
Recently, I was given an article about diversification, the challenges it presents, and how it seems to be most extreme for companies in medical related fields. I called Elizabeth Young, an experienced Senior Director, with proven global experience in Medical Devices, Healthcare, and Biotech industries, and asked her about this issue. Medical device companies may
- Published in View Point